Symmetric Tip Catheter
DeviceDialysis catheter
NCT Number: NCT00526123
The purpose of this clinical trial is to compare the longevity of two dialysis catheters.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nephrology Associates, P.C., Birmingham, Alabama, United States
This study is a multi-center, randomized, prospective, open-label, clinical study comparing a conventional split-tip catheter and a symmetric tip catheter in subjects undergoing hemodialysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dialysis catheter
Dialysis Catheter
Time frame: 30 days
% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.
Time frame: 60 days
% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.
Time frame: 245 days
% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.
Time frame: 35 weeks
Number of events per study group in which the first catheter induced complication was 'inadequate flow requiring surgical/radiological intervention'.
Time frame: 35 Weeks
Average number of times the dialysis lines were reversed per subject to deliver dialysis treatments
Time frame: 35 Weeks
Average number of times clinician intervention was required for either catheter malfunction or infection
Time frame: First dialysis session with study catheter
The percentage of catheters unable to deliver adequate blood flow of at least 300 mL/min for at least 50% of measurements during the first attempted dialysis session.
Time frame: 35 Weeks
Percentage of study visits in which the median blood flow rate was greater than or equal to 300 mL/min.
Tyco Healthcare Group
Industry
A Randomized, Open-label Comparison of the Performance and Longevity of a Split-tip Versus a Symmetric Tip Hemodialysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03719339
Acute Cellular Graft Rejection, Antibody-mediated Rejection
La Jolla, California, United States
View Trial DetailsNCT03534284
Chronic Disease, Disease Attributes
Seattle, Washington, United States
View Trial DetailsNCT03329521
Chronic Disease, Disease Attributes
London, Ontario, Canada
View Trial DetailsNCT04125537
Chronic Disease, Chronic Kidney Disease Requiring Chronic Dialysis
Arvada, Colorado, United States
View Trial Details